Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Vaccine - 16 Oct 2007

Smallshaw Joan E, Richardson James A, Vitetta Ellen S

Abstract excerpt

Ricin is a plant toxin that is a CDC level B biothreat. Our recombinant ricin A chain vaccine (RiVax), which contains mutations in both known toxic sites, has no residual toxicity at doses at least 800 times the immunogenic dose. RiVax without adjuvant given intramuscularly (i.m.) protected mice...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Administration, Oral
Share to Injections, Intramuscular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lethal Dose 50

Share to Plants, Toxic

Share to Vaccines

Share to Vaccines, Synthetic

Source

Open in PubMed Open full text

Identifiers

PMID: 17875350
DOI: 10.1016/j.vaccine.2007.08.018
PMCID: PMC2049008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17875350-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.PMID 17875350Read ↗

Ricin: An Ancient Story for a Timeless Plant ToxinSemantic proximity Read ↗

Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.Semantic proximity Read ↗

Disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate RTA1-33/44-198.Semantic proximity Read ↗

Characterization of prokaryotic recombinant Aspergillus ribotoxin alpha-sarcin.Semantic proximity Read ↗

High-level expression and simplified purification of recombinant ricin A chain.Semantic proximity Read ↗

Catalytic and cytotoxic activities of recombinant ricin A chain mutants with charged residues added at the carboxyl terminus.Semantic proximity Read ↗

Assessment of potential adjuvanticity of Cry proteins.Semantic proximity Read ↗

Safety, Immunogenicity and Efficacy of Relcovax®, A Dual Receptor Binding Domain (RBD) and Nucleocapsid (NC) Subunit Protein Vaccine Candidate Against SARS-CoV-2 VirusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.